The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Shree Ganesh Remedies Ltd

Shree Ganesh Remedies Ltd

BSE 540737 · NSE SGRL · ISIN INE414Y01015 · Group B · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹545.00

+5.07%

BSE close, 28 August 2026

Market cap

₹699.50 cr

1.3 cr shares · Micro cap

Free float

₹189.80 cr

as published

P/E · P/B

45.3× · 5.25×

EPS ₹12.03 · BV ₹103.81

FY25-26 rev / PAT

109.29 / 17.77

₹ cr, as filed

Filings, window

9

4 selected · 44%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹381.10 52-WK HIGH ₹759.00 ₹545.00 43% of range
Against 52-week high-28.2%
Against 52-week low+43.0%
Day change+5.07%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹12.03
Price / earnings45.30×
Price / book5.25×
Book value — derived, price ÷ P/B₹103.81
Return on equity11.60%
Operating margin29.88%
Net margin7.80%

Consistency check

P/B ÷ P/E, which must equal ROE
11.59%
ROE as published
11.60%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 14.36 1.12 0.87 29.88% 7.80%
Mar-26 · Q 33.20 6.27 4.88 37.34% 18.89%
FY25-26 109.29 17.77 13.84 34.82% 16.26%

Quarter on quarter

Revenue, quarter on quarter
-56.7%
Net profit, quarter on quarter
-82.1%
Operating margin, quarter on quarter
-746 bps

Disclosure profile 9 filings in the window

0 median 17.0 p75 · 25 sector max 52 9 11th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Investor Presentation1
Press Release1
Results1
Selected sub-total4
Procedural
Newspaper Publication2
Annual Report1
Compliance Certificate1
General1
Procedural sub-total5
Total9

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

9 filings · 4 selected · busiest 2026-08-12 and 2026-08-13

Filing rhythm · the twelve most recent

2026-08-122026-10-09

SelectedProcedural

Filings

9 in the window · 6 earlier on record

  1. 9 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Compliances - Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  2. 21 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper Publication for Notice of Annual General Meeting

    Company Update / Newspaper Publication View filing →

  3. 20 August 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Annual Report FY 2025-26

    Others / Reg. 34 (1) Annual Report View filing →

  4. 13 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper Publication

    Company Update / Newspaper Publication View filing →

  5. 13 August 2026 ·

    Investor Presentation

    Investor Presentation

    Investor Presentation

    Company Update / Investor Presentation View filing →

  6. 13 August 2026 ·

    Press Release

    Press Release / Media Release

    Press Release

    Company Update / Press Release / Media Release View filing →

  7. 12 August 2026 ·

    General

    Appointment Of Cost Auditors

    Appointment of Cost Auditors

    Company Update / General View filing →

  8. 12 August 2026 ·

    Results

    Results - Financial Results For The Quarter Ended On June 30, 2026

    Financial Results for the quarter ended on June 30, 2026

    Result / Financial Results View filing →

  9. 12 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting

    Outcome of Board Meeting

    Board Meeting / Outcome of Board Meeting View filing →

RSS feed for Shree Ganesh Remedies Ltd · the 50 most recent filings